JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$2.01B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.93B |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$1.27B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$920M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$909M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.06B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$2.61B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.47B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.26B |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$990M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.29% |
| 2 | Technology | 12.89% |
| 3 | Financials | 12.24% |
| 4 | Healthcare | 8.95% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3051
First Financial Corp
THFF
$892M
| $2.79M | ﹤0.01% |
64,307
-29,855
| -32% | -$1.24M |
2013 Q2
25 quarters
|
|
|
UCFC
3052
DELISTED
United Community Financial Corp
UCFC
| $2.78M | ﹤0.01% |
257,811
+122,238
| +90% | +$1.21M |
2014 Q4
19 quarters
|
|
3053
CALL
AB InBev
BUD
$145B
| $2.78M | ﹤0.01% |
+29,200
| New | +$2.77M |
2019 Q3
0 quarters
|
|
3054
Enovis
ENOV
$1.02B
| $2.77M | ﹤0.01% |
55,358
+19,539
| +55% | +$922K |
2018 Q3
4 quarters
|
|
|
BLUE
3055
PUT
DELISTED
bluebird bio
BLUE
| $2.75M | ﹤0.01% |
2,316
-6,755
| -74% | -$10.3M |
2019 Q2
1 quarter
|
|
|
RPT
3056
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $2.75M | ﹤0.01% |
202,748
+68,345
| +51% | +$842K |
2013 Q2
25 quarters
|
|
|
UBNK
3057
DELISTED
United Financial Bancorp, Inc.
UBNK
| $2.74M | ﹤0.01% |
201,377
+42,556
| +27% | +$575K |
2013 Q2
25 quarters
|
|
|
SNCR
3058
DELISTED
Synchronoss Technologies
SNCR
| $2.74M | ﹤0.01% |
56,384
+1,615
| +3% | +$110K |
2018 Q4
3 quarters
|
|
3059
ArcelorMittal
MT
$48.5B
| $2.74M | ﹤0.01% |
192,467
-521,069
| -73% | -$8M |
2013 Q2
25 quarters
|
|
3060
Rhythm Pharmaceuticals
RYTM
$6.39B
| $2.73M | ﹤0.01% |
126,544
-291
| -0.2% | -$6.24K |
2017 Q4
7 quarters
|
|
3061
Assembly Biosciences
ASMB
$459M
| $2.72M | ﹤0.01% |
23,076
+4,654
| +25% | +$704K |
2017 Q2
9 quarters
|
|
3062
PUT
Lyft
LYFT
$5.85B
| $2.72M | ﹤0.01% |
+66,600
| New | +$3.64M |
2019 Q3
0 quarters
|
|
3063
News Corp Class B
NWS
$17.1B
| $2.72M | ﹤0.01% |
190,080
+28,000
| +17% | +$393K |
2015 Q3
16 quarters
|
|
3064
CALL
Allstate
ALL
$56.6B
| $2.72M | ﹤0.01% |
25,000
| – | – |
2018 Q4
3 quarters
|
|
3065
PUT
Tractor Supply
TSCO
$16.2B
| $2.71M | ﹤0.01% |
+150,000
| New | +$3.11M |
2019 Q3
0 quarters
|
|
3066
CALL
uniQure
QURE
$1.63B
| $2.71M | ﹤0.01% |
68,900
+24,100
| +54% | +$1.39M |
2018 Q3
4 quarters
|
|
3067
Santander
BSBR
$40.4B
| $2.71M | ﹤0.01% |
259,809
+21,817
| +9% | +$233K |
2015 Q3
16 quarters
|
|
3068
PUT
Kimco Realty
KIM
$14.9B
| $2.71M | ﹤0.01% |
129,800
-137,300
| -51% | -$2.61M |
2019 Q1
2 quarters
|
|
3069
Mitsubishi UFJ Financial
MUFG
$257B
| $2.71M | ﹤0.01% |
533,193
+24,648
| +5% | +$121K |
2013 Q2
25 quarters
|
|
3070
Martin Midstream Partners
MMLP
$85.3M
| $2.71M | ﹤0.01% |
596,046
+127,753
| +27% | +$658K |
2014 Q4
19 quarters
|
|
3071
Vanda Pharmaceuticals
VNDA
$280M
| $2.7M | ﹤0.01% |
203,325
-97,602
| -32% | -$1.36M |
2015 Q4
15 quarters
|
|
|
AIMT
3072
DELISTED
Aimmune Therapeutics
AIMT
| $2.7M | ﹤0.01% |
128,715
+6,787
| +6% | +$139K |
2016 Q1
14 quarters
|
|
3073
First Trust Enhanced Short Maturity ETF
FTSM
$6.59B
| $2.69M | ﹤0.01% |
44,864
-31,804
| -41% | -$1.91M |
2016 Q4
11 quarters
|
|
|
TLRD
3074
DELISTED
Tailored Brands, Inc.
TLRD
| $2.69M | ﹤0.01% |
611,193
+279,457
| +84% | +$1.42M |
2016 Q1
14 quarters
|
|
3075
Phibro Animal Health
PAHC
$1.51B
| $2.69M | ﹤0.01% |
125,938
-161,934
| -56% | -$4.44M |
2014 Q2
21 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2019 Portfolio in Review
As of Q3 2019, JP Morgan Chase held 6,188 positions worth $502B, down 1.8% from $511B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2019 filing shows 385 new, 2,786 increased, 1,863 reduced and 426 closed positions. Its largest new stake was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $3.06B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2019 buy was Cushing 30 MLP Index ETNs due June 15, 2037: 4,695,000 shares worth $75.6M.
- JP Morgan Chase added most to iShares 7-10 Year Treasury Bond ETF in Q3 2019, an estimated $2.01B increase.
- JP Morgan Chase's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.06B.
- JP Morgan Chase fully exited Worldpay, Inc. in Q3 2019, selling an estimated $372M.
- JP Morgan Chase's ten largest holdings make up 16% of its $502B portfolio in Q3 2019.
- JP Morgan Chase opened 385 new positions and closed 426 in Q3 2019.
- JP Morgan Chase's portfolio value fell 1.8% quarter-over-quarter to $502B.
Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.